LKM1 autoantibodies in chronic hepatitis C infection: a case of molecular mimicry? (Q33220129)

24 July 2017

LKM1 autoantibodies in chronic hepatitis C infection: a case of molecular mimicry? (English)

1 reference

24 July 2017

1 reference

1 reference

1 reference

1 reference

Gabriel Marceau

1

0 references

Pascal Lapierre

object named as

Pascal Lapierre

series ordinal

2

0 references

Hugo Soudeyns

series ordinal

4

object named as

Hugo Soudeyns

1 reference

24 July 2017

Kathie Béland

3

1 reference

PubMed ID

16037945

24 July 2017

Fernando Alvarez

series ordinal

5

1 reference

PubMed ID

16037945

24 July 2017

language of work or name

English

0 references

publication date

1 September 2005

1 reference

24 July 2017

1 reference

24 July 2017

42

1 reference

24 July 2017

3

1 reference

24 July 2017

675-682

1 reference

Prediction of the immunodominant epitope of the pyruvate dehydrogenase complex E2 in primary biliary cirrhosis using phage display.

24 July 2017

1 reference

Frequency and significance of antibody to hepatitis C virus in severe corticosteroid-treated autoimmune chronic active hepatitis

21 January 2018

1 reference

Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease.

21 January 2018

1 reference

Chronic liver disease mortality in the United States, 1990-1998.

21 January 2018

1 reference

7 January 2021

Anti-HCV testing in autoimmune hepatitis and primary biliary cirrhosis

1 reference

7 January 2021

High prevalence of antibodies to hepatitis C virus (HCV) in patients with anti-thyroid autoantibodies

1 reference

7 January 2021

Membranoproliferative glomerulonephritis associated with hepatitis C virus infection

1 reference

7 January 2021

Anti-GOR antibodies in lichen planus

1 reference

7 January 2021

Extrahepatic manifestations of hepatitis C infection

1 reference

7 January 2021

Anti-LKM-1 antibodies determined by use of recombinant P450 2D6 in ELISA and western blot and their association with anti-HCV and HCV-RNA

1 reference

7 January 2021

Hepatitis C and D, retroviruses and autoimmune manifestations

1 reference

7 January 2021

Non--Organ-Specific Autoantibodies in Children with Chronic Hepatitis C: Clinical Significance and Impact on Interferon Treatment

1 reference

7 January 2021

Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C.

1 reference

7 January 2021

Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.

1 reference

7 January 2021

Anti-liver-kidney microsome antibody type 1 recognizes human cytochrome P450 db1.

1 reference

7 January 2021

Characterization of anti-liver-kidney microsome antibody (anti-LKM1) from hepatitis C virus-positive and -negative sera.

1 reference

7 January 2021

Study of the B cell response to cytochrome P450IID6 in sera from chronic hepatitis C patients

1 reference

7 January 2021

The mapping and reconstitution of a conformational discontinuous B-cell epitope of HIV-1.

1 reference

7 January 2021

Continuous and discontinuous protein antigenic determinants

1 reference

7 January 2021

Autoantibody detection in type 2 autoimmune hepatitis using a chimera recombinant protein

1 reference

7 January 2021

Genetic bases of autoimmune hepatitis.

1 reference

7 January 2021

Multiple viral/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51.

1 reference

7 January 2021

Analytical study of microsomes and isolated subcellular membranes from rat liver. II. Preparation and composition of the microsomal fraction

1 reference

7 January 2021

Homology modelling of human CYP2 family enzymes based on the CYP2C5 crystal structure

1 reference

7 January 2021

SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling

1 reference

7 January 2021

Anti-LC1 autoantibodies in patients with chronic hepatitis C virus infection

1 reference

7 January 2021

Type 2 autoimmune hepatitis and hepatitis C virus infection

1 reference

7 January 2021

A novel assay for detecting antibodies to cytochrome P4502D6, the molecular target of liver kidney microsomal antibody type 1

1 reference

7 January 2021

A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens

1 reference

7 January 2021

Identification and analysis of cytochrome P450IID6 antigenic sites recognized by anti-liver-kidney microsome type-1 antibodies (LKM1)

1 reference

7 January 2021

Antibody-selectable filamentous fd phage vectors: affinity purification of target genes

1 reference

7 January 2021

Structure and function of the membrane anchor domain of hepatitis C virus nonstructural protein 5A.

1 reference

7 January 2021

Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase

1 reference

7 January 2021

1 reference

7 January 2021

Protein structure alignment by incremental combinatorial extension (CE) of the optimal path

1 reference

7 January 2021

Beta-Ala containing peptides: potentials in design and construction of bioactive peptides and protein secondary structure mimics

1 reference

7 January 2021

10 residue folded peptide designed by segment statistics.

1 reference

7 January 2021

Non-organ specific autoantibodies in children with chronic hepatitis C.

1 reference

7 January 2021

Autoantibody prevalence in children with liver disease due to chronic hepatitis C virus (HCV) infection

1 reference

7 January 2021

Hepatitis C virus infection associated with liver-kidney microsomal antibody type 1 (LKM1) autoantibodies in children.

1 reference

7 January 2021

Interferon therapy in liver/kidney microsomal antibody type 1-positive patients with chronic hepatitis C.

1 reference

7 January 2021

Efficacy and safety of interferon alfa therapy in chronic hepatitis C with autoantibodies to liver-kidney microsomes

1 reference

7 January 2021

LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase

1 reference

7 January 2021

Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20816

1 reference

24 July 2017

1 reference

PubMed ID

16037945